![cat](https://i0.wp.com/www.mychesco.com/wp-content/uploads/2022/08/cat_outside-kornyeyeva-gettyimages.jpg?resize=735%2C400&ssl=1)
FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease
The U.S. Food and Drug Administration announced it recently conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of nonregenerative anemia associated with chronic kidney disease (CKD) …
FDA Conditionally Approves First Drug for Anemia in Cats with Chronic Kidney Disease Read More